title: Transplantation: rituximab induction only for sensitized kidney recipients?
abstract: In contrast to earlier studies that showed a beneficial influence of rituximab on HLA antibody production after kidney transplantation, a recent report by Ashimine et al. questions such an effect. That previous studies included presensitized patients who are more prone to antibody development, might explain this controversy.
authors.affiliation: Department of Nephrology, University of Heidelberg, Im Neuenheimer Feld 672, 69120 Heidelberg, Germany.
authors.forename: Christian
authors.initials: C
authors.lastname: Morath
authors.forename: Caner
authors.initials: C
authors.lastname: Süsal
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D005260:Female; D006680:HLA Antigens / Q000276:immunology*; D006648:Histocompatibility; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007518:Isoantibodies / Q000097:blood*; D016030:Kidney Transplantation; D008297:Male; D013156:Splenectomy
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D006680:HLA Antigens; D007166:Immunosuppressive Agents; D007518:Isoantibodies